Literature DB >> 20738215

Pharmacological studies on Hypericum perforatum fractions and constituents.

Arif-ullah Khan1, Anwarul-Hassan Gilani.   

Abstract

CONTEXT: This study describes the antispasmodic, bronchodilator, and cardiovascular-modulatory activities of Hypericum perforatum Linn. (Hypericaceae) fractions and constituents.
AIM OF STUDY: Pharmacological investigation of H. perforatum fractions and active principles.
MATERIALS AND METHODS: H. perforatum extract fractions [petroleum spirit (HpPet), chloroform (HpCHCl(3)), ethyl acetate (HpEtAc), and aqueous (HpAq)] and its compounds (hyperforin, hypericin, and hyperoside) were studied in various isolated tissue preparations.
RESULTS: In rabbit jejunum, HpCHCl(3), HpEtAc and HpAq, like papaverine, inhibited both spontaneous and K(+) (80 mM)-induced contractions at similar concentrations, whereas HpPet was relatively potent against K(+), as verapamil. All fractions caused rightward of Ca(2+) concentration-response curves (CRCs), similar to verapamil. HpCHCl(3), HpEtAc, and HpAq shifted isoprenaline-inhibitory CRCs to left, like papaverine, while HpPet was devoid of any such effect, as verapamil. In guinea-pig trachea, HpCHCl(3), HpEtAc, and HpAq equipotently relaxed carbachol and K(+)-induced contractions and shifted the isoprenaline-curves to the left, whereas HpPet was more effective against K(+), without potentiating isoprenaline effect. When tested in rabbit aorta, all fractions exhibited vasoconstrictor and vasodilator effects, except HpEtAc, which did not produce vasoconstriction. In guinea-pig atria HpCHCl(3), HpEtAc, and HpAq initially caused cardiac stimulation, followed by inhibition, similar to papaverine, whereas HpPet, like verapamil, caused only cardiac suppression. Hyperforin, hypericin, and hyperoside showed a similar pattern of spasmolytic effect to verapamil. DISCUSSION AND
CONCLUSION: Thus, all tested fractions of H. perforatum exhibit a combination of Ca(2+) antagonist and phosphodiesterase-inhibition, except petroleum spirit which was devoid of later mechanism. The compounds tested showed only Ca(2+) channel blocking effect.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20738215     DOI: 10.3109/13880209.2010.494307

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  7 in total

Review 1.  Hepatoprotective Essential Oils: A Review.

Authors:  Nour Elhouda Daoudi; Mohamed Bnouham
Journal:  J Pharmacopuncture       Date:  2020-09-30

2.  Antispasmodic, bronchodilator, vasorelaxant and cardiosuppressant effects of Buxus papillosa.

Authors:  Arif-Ullah Khan; Shamsher Ali; Anwarul-Hassan Gilani; Manzoor Ahmed; Muhammad Iqbal Choudhary
Journal:  BMC Complement Altern Med       Date:  2017-01-18       Impact factor: 3.659

Review 3.  Natural Antispasmodics: Source, Stereochemical Configuration, and Biological Activity.

Authors:  Edith Fabiola Martínez-Pérez; Zaida N Juárez; Luis R Hernández; Horacio Bach
Journal:  Biomed Res Int       Date:  2018-10-08       Impact factor: 3.411

Review 4.  Antispasmodic Potential of Medicinal Plants: A Comprehensive Review.

Authors:  Abdur Rauf; Muhammad Akram; Prabhakar Semwal; Adil A H Mujawah; Naveed Muhammad; Zerfishan Riaz; Naveed Munir; Dmitry Piotrovsky; Irina Vdovina; Abdelhakim Bouyahya; Charles Oluwaseun Adetunji; Mohammad Ali Shariati; Zainab M Almarhoon; Yahia N Mabkhot; Haroon Khan
Journal:  Oxid Med Cell Longev       Date:  2021-11-11       Impact factor: 6.543

5.  Effects of Extracts and Flavonoids from Drosera rotundifolia L. on Ciliary Beat Frequency and Murine Airway Smooth Muscle.

Authors:  Alexander Hake; Frank Begrow; Verena Spiegler; Nico Symma; Andreas Hensel; Martina Düfer
Journal:  Molecules       Date:  2022-10-05       Impact factor: 4.927

Review 6.  Roles of chemical complexity and evolutionary theory in some hepatic and intestinal enzymatic systems in chemical reproducibility and clinical efficiency of herbal derivatives.

Authors:  Francesco Di Pierro
Journal:  ScientificWorldJournal       Date:  2014-04-06

Review 7.  Awareness and Current Therapeutics of Asthma.

Authors:  Rida Zainab; Muhammad Akram; Muhammad Daniyal; Muhammad Riaz
Journal:  Dose Response       Date:  2019-09-04       Impact factor: 2.658

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.